Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRIT Capital Partners Regulatory News (RCP)

Share Price Information for RIT Capital Partners (RCP)

Share Price is delayed by 15 minutes
Get Live Data
2,320.00    -10.00 (-0.43%)
Bid:
2,320.00
Ask:
2,325.00
Spread: 5.00 (0.216%)
Market Cap: £3.15b
RCP Live PriceLast checked at - London Stock Exchange

Intraday RIT Capital Partners Share Chart

Net Asset Value(s)

16 Aug 2024 07:00

RNS Number : 6580A
RIT Capital Partners PLC
16 August 2024
 

RIT Capital Partners plc (LEI: P31Q1NLTW35JJGHA4667)

 

16 August 2024

 

31 July 2024 Net Asset Value

 

RIT Capital Partners plc announces that its unaudited diluted net asset value ("NAV") as at 31 July 2024 (with debt at fair value) was 2,560p per £1 ordinary share (30 June 2024: 2,508p).

 

July 2024 Market Commentary

 

The MSCI ACWI (50% £) ended the month +0.6% up, largely driven by the US market which benefited from a rally in small and medium sized ("SMID cap") stocks. In contrast, concerns over the growth outlook in Europe and Asia weighed on market sentiment in these regions. Notably, the UK performed strongly following the general election.

 

Portfolio Highlights

 

Our portfolio outperformed both our global equities and inflation hurdles during the month against a volatile backdrop for global equities with a positive performance of +2.1% for the month, driven by strong gains in our Quoted Equities pillar, while our Private Investments and Uncorrelated Strategies pillars remained largely flat. Our meaningful US dollar position detracted from returns as sterling rallied in the wake of the UK general election.

 

Specific highlights for July include:

 

·

Strong performance across our Quoted Equities book (both direct and underlying managers), in part driven by our exposure to SMID cap, healthcare and cyclical stocks which fared particularly well. Our exposure to Japan was also a positive contributor, despite the small decline in the TOPIX index during the period.

 

·

Private Investments' performance was broadly flat across the pillar. As reported in our Interim Results, there were further realisations during the month of July and we continue to see positive indicators in the market that this momentum should continue.

 

·

Investments in Uncorrelated Strategies were also flat during the period, with marginally positive contributions across credit strategies, gold and government bonds and a modest decline in performance in California carbon credits.

 

 

For more information:

J. Rothschild Capital Management Limited (Manager):

T: 020 7647 8565

E: investorrelations@ritcap.co.uk

 

Numis Securities Limited (Joint Broker):

David Benda

T: 020 7260 1000

 

JP Morgan Cazenove (Joint Broker):

William Simmonds

T: 020 3493 8000

 

Brunswick Group LLP (Media enquiries):

Nick Cosgrove, Sofie Brewis

T: 020 7404 5959

E: RIT@BrunswickGroup.com 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVEELFFZVLXBBF
Date   Source Headline
3rd Mar 20267:00 amRNSFinal Results
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 202610:44 amRNSTotal Voting Rights
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSNet Asset Value(s)
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSNet Asset Value(s)
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 202612:37 pmRNSTotal Voting Rights
2nd Feb 20267:00 amRNSTransaction in Own Shares
30th Jan 20267:00 amRNSTransaction in Own Shares
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSTransaction in Own Shares
23rd Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
19th Jan 20267:00 amRNSTransaction in Own Shares
16th Jan 20267:00 amRNSTransaction in Own Shares
14th Jan 20267:00 amRNSTransaction in Own Shares
8th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20267:00 amRNSTransaction in Own Shares
5th Jan 202610:44 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20267:00 amRNSTransaction in Own Shares
31st Dec 20251:28 pmRNSShare Buyback Management
31st Dec 20251:28 pmRNSShare Buyback Management
31st Dec 20257:00 amRNSTransaction in Own Shares
31st Dec 20257:00 amRNSTransaction in Own Shares
30th Dec 20257:00 amRNSTransaction in Own Shares
30th Dec 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.